Kidneys are the main metabolism organ of human body, when there are some
disorder in kidneys, patients would suffer some abnormal condition. Now there is
a introduction about these symptoms of kidney disorder, which really need the
attention of patients to prevent CKD for a timely and effective treatment.
1. Note if you have any changes in your urination habits. You may frequently
have the urge to urinate but when you go to the bathroom, nothing happens. If
the urine volume increase suddenly when you do not drink much water, sweat a
lot, or do exercises, it may also indicate IgA Nephropathy.
2. Check if your urine is bubbly, foamy, very pale or darker than usual. You
may also have blood in urine, in which case you should see a doctor
immediately.
3. Look if you have any strange edema in your ankles, feet, legs or hands. If
the kidneys are damaged, they are unable to remove excess fluids, which start to
build up in other parts of your body.
4. Notice if your sleeping habits change. As your kidneys fail, there is less
oxygen in your blood than normal. This is called anemia and causes fatigue.
5. Check for extraneous pain in your back or side. Often the side with the
afflicted kidney will become sore.
6. Note if you have high blood pressure. As the initial symptom of many
patients, high blood pressure is a factor which leads to grim prognosis.
Patients who want to get rid of these symptoms need try their best to reverse
the kidney functions. Micro-Chinese Medicine Osmotherapy is the best choice for
patients.
All in all, any symptom need our attention. The timely and effective
treatment for the kidney disorder plays an important role in living a normal and
long life. And now if you want to know more information about the symptoms of
kidney disorder or ask for treatment suggestions, you can contact our online
doctors, leave us messages or send email to kidneyhospitalabroad@hotmail.com, we
will reply you within 24 hours.
Saturday, April 25, 2015
Friday, April 24, 2015
High Fever in Patients with IgA Nephropathy: Cause and Treatment
Some IgA Nephropathy patients may suffer from high fever, with the chronic
and persistent high fever, other tissues are bothered and influenced. The sever
pains also urge patients to know the cause and management for the high fever in
IgA Nephropathy.
Let′s talk about fever firstly. In fact, fever is the body′s natural way to protect itself from invaders like bacteria and virus, because many of them are no able to survive in the body due to the high temperature caused by a fever.
High temperature is also a signal that the infection-fighting cells of the immune system including phagocytes, neutrophils, and lymphocytes come to the body′s defence and assist with fighting against infections.
Causes of high fever in IgA Nephropathy
IgA Nephropathy is a chronic form of glomerulonephritis marked by a hematuria and proteinuria and by the depositions of immunoglobulin A in the mesangial areas of the renal glomeruli, with subsequent reactive hyperplasia of mesangial cells. Upper respiratory tract infection often happens before the onset.
High fever in IgA Nephropathy may appear as a result of infection. When people are affected by an infection, or inflammation, the body will produce substances called pyrogens. It is the pyrogens that actually cause the high fever.
Symptoms of high fever in IgA Nephropathy
If persons with IgA Nephropathy have a high fever, the muscles might repeatedly contract to keep the body warm, causing shivering. Sometimes, chills occur when this happens.
IgA Nephropathy is not a benign disease, and many people may progress into Renal Failure if improperly treated. At present, Micro-Chinese Medicine Osmotherapy is the latest treatment for IgA Nephropathy, which can guarantee the best curative effects.
Now if you want to know more information about the cause and management for high fever in IgA Nephropathy, you can contact our online doctors, leave us messages or send email to kidneyhospitalabroad@hotmail.com, we will reply you within 24 hours.
Let′s talk about fever firstly. In fact, fever is the body′s natural way to protect itself from invaders like bacteria and virus, because many of them are no able to survive in the body due to the high temperature caused by a fever.
High temperature is also a signal that the infection-fighting cells of the immune system including phagocytes, neutrophils, and lymphocytes come to the body′s defence and assist with fighting against infections.
Causes of high fever in IgA Nephropathy
IgA Nephropathy is a chronic form of glomerulonephritis marked by a hematuria and proteinuria and by the depositions of immunoglobulin A in the mesangial areas of the renal glomeruli, with subsequent reactive hyperplasia of mesangial cells. Upper respiratory tract infection often happens before the onset.
High fever in IgA Nephropathy may appear as a result of infection. When people are affected by an infection, or inflammation, the body will produce substances called pyrogens. It is the pyrogens that actually cause the high fever.
Symptoms of high fever in IgA Nephropathy
If persons with IgA Nephropathy have a high fever, the muscles might repeatedly contract to keep the body warm, causing shivering. Sometimes, chills occur when this happens.
IgA Nephropathy is not a benign disease, and many people may progress into Renal Failure if improperly treated. At present, Micro-Chinese Medicine Osmotherapy is the latest treatment for IgA Nephropathy, which can guarantee the best curative effects.
Now if you want to know more information about the cause and management for high fever in IgA Nephropathy, you can contact our online doctors, leave us messages or send email to kidneyhospitalabroad@hotmail.com, we will reply you within 24 hours.
Urine Change in IgA Nephropathy: Cause and Management
Urine change is the common sign of kidney function disorder. So when people
are attacked by IgA Nephropathy, patients may find disorder in their urine. How
the proper symptoms in urine may occur, patients can have a timely prevention
and treatment. This article would have a analysis.
Hematuria can be found by observing urine. Hematuria can be divided into gross hematuria and microscopic hematuria. Simply speaking, gross hematuria or macroscopic hematuria refers to that the urine is bloody, which is visible to the naked eye. So if you find you have blood urine for 3 to 7 days and you have no history of hurting urinary tract, you had better to see a doctor and take a urine test.
To patients with IgA Nephropathy, their urine will be dark in 3 days after some infections, such as cold. The dark red urine can last for several days to even several weeks, then the color of urine turn to light. It is necessary for people to take a urine test after one week dark urine. Usually, gross hematuria means that their kidneys are under the situation of acute glomerulonephritis, and microscopic hematuria means that their kidneys are under microinflammation state. Due to inflammation, calculus, tumor, injury, congenital malformation are the common causes for hematuria, if you want to make sure the real reason, you can take blood test or test for kidneys.
Bubbles in urine is another signal for IgA Nephropathy. If you have bubbles for more than one month and you have no Diabetes, the bubbles in urine maybe leaked protein. You should pay attention first to make sure you don′t have too much protein, then observe the urine again. If the bubbles still in urine, it maybe proteinurine.
we know, glomerulus blood capillary has good permeability on water and electrolyte, but big molecular protein can not be eliminated from the glomerulus blood capillary. So, protein urine can indicate the damage on glomerulus blood capillary. Most patients with IgA Nephropathy has proteinurine and over 60% of them go to see a doctor for bubbles in urine.
IgA Nephropathy patients should have a timely and effective treatment when there are some disorder in their urine, you can contact our online doctors, leave us messages or send email to kidneyhospitalabroad@hotmail.com for more questions or ask for treatment suggestions, we will reply you within 24 hours.
Hematuria can be found by observing urine. Hematuria can be divided into gross hematuria and microscopic hematuria. Simply speaking, gross hematuria or macroscopic hematuria refers to that the urine is bloody, which is visible to the naked eye. So if you find you have blood urine for 3 to 7 days and you have no history of hurting urinary tract, you had better to see a doctor and take a urine test.
To patients with IgA Nephropathy, their urine will be dark in 3 days after some infections, such as cold. The dark red urine can last for several days to even several weeks, then the color of urine turn to light. It is necessary for people to take a urine test after one week dark urine. Usually, gross hematuria means that their kidneys are under the situation of acute glomerulonephritis, and microscopic hematuria means that their kidneys are under microinflammation state. Due to inflammation, calculus, tumor, injury, congenital malformation are the common causes for hematuria, if you want to make sure the real reason, you can take blood test or test for kidneys.
Bubbles in urine is another signal for IgA Nephropathy. If you have bubbles for more than one month and you have no Diabetes, the bubbles in urine maybe leaked protein. You should pay attention first to make sure you don′t have too much protein, then observe the urine again. If the bubbles still in urine, it maybe proteinurine.
we know, glomerulus blood capillary has good permeability on water and electrolyte, but big molecular protein can not be eliminated from the glomerulus blood capillary. So, protein urine can indicate the damage on glomerulus blood capillary. Most patients with IgA Nephropathy has proteinurine and over 60% of them go to see a doctor for bubbles in urine.
IgA Nephropathy patients should have a timely and effective treatment when there are some disorder in their urine, you can contact our online doctors, leave us messages or send email to kidneyhospitalabroad@hotmail.com for more questions or ask for treatment suggestions, we will reply you within 24 hours.
Treatment of Primary Focal Segmental Glomerulosclerosis
Primary focal segmental glomerulosclerosis is showing as nephrotic syndrome
including the lots of protein urine, serious edema, hypoproteinemia and
hyperlipidaemia. But in this period, FSGS patients still are in the reversible
period with a effective control and treatment. This article would have a
introduction about the primary FSGS.
Focal and segmental glomerulosclerosis is a morphologic pattern of glomerular injury primarily directed at the glomerular visceral epithelial cell and defined by the presence of sclerosis in parts of some glomeruli by light microscopy of a renal biopsy specimen. The lesion may be found either without an identifiable cause or in response to previous glomerular injury, glomerular hypertension, or hypertrophy FSGS is distinct from focal and global glomerulosclerosis, which has a different prognosis and treatment.
Primary FSGS can present acutely with overt nephrotic syndrome characterized by hypoalbuminemia and edema. However, primary FSGS can also present insidiously with less dramatic manifestations, possibly related to the underlying histologic variant. The diagnosis of primary FSGS is confirmed by a renal biopsy that reveals the morphologic features mentioned above plus diffuse (greater than 80 percent) effacement of the foot processes by electron microscopy. In contrast, secondary FSGS most often presents as asymptomatic proteinuria without hypoalbuminemia or edema. In addition, the kidney biopsy usually reveals glomerulomegaly, focal (rather than diffuse) foot process effacement, and, sometimes, evidence of a separate kidney disease that is responsible for the development of secondary FSGS.
Renin-angiotensin-aldosterone system blockade (with angiotensin-converting enzyme [ACE] inhibitors or angiotensin receptor blockers [ARBs]) reduces proteinuria and slows progression in proteinuric kidney diseases. However, whether or not this is effective in primary FSGS is unknown.
All in all, controlling complications such as high blood pressure, protein urine and anemia is necessary to protect the kidney functions. primary focal segmental glomerulosclerosis patients should try their best to find the therapy to reverse kidney function. Now if you want to know more information about FSGS or ask for treatment suggestions, you can contact our online doctors, leave us messages or send email to kidneyhospitalabroad@hotmail.com, we will reply you within 24 hours.
Focal and segmental glomerulosclerosis is a morphologic pattern of glomerular injury primarily directed at the glomerular visceral epithelial cell and defined by the presence of sclerosis in parts of some glomeruli by light microscopy of a renal biopsy specimen. The lesion may be found either without an identifiable cause or in response to previous glomerular injury, glomerular hypertension, or hypertrophy FSGS is distinct from focal and global glomerulosclerosis, which has a different prognosis and treatment.
Primary FSGS can present acutely with overt nephrotic syndrome characterized by hypoalbuminemia and edema. However, primary FSGS can also present insidiously with less dramatic manifestations, possibly related to the underlying histologic variant. The diagnosis of primary FSGS is confirmed by a renal biopsy that reveals the morphologic features mentioned above plus diffuse (greater than 80 percent) effacement of the foot processes by electron microscopy. In contrast, secondary FSGS most often presents as asymptomatic proteinuria without hypoalbuminemia or edema. In addition, the kidney biopsy usually reveals glomerulomegaly, focal (rather than diffuse) foot process effacement, and, sometimes, evidence of a separate kidney disease that is responsible for the development of secondary FSGS.
Renin-angiotensin-aldosterone system blockade (with angiotensin-converting enzyme [ACE] inhibitors or angiotensin receptor blockers [ARBs]) reduces proteinuria and slows progression in proteinuric kidney diseases. However, whether or not this is effective in primary FSGS is unknown.
All in all, controlling complications such as high blood pressure, protein urine and anemia is necessary to protect the kidney functions. primary focal segmental glomerulosclerosis patients should try their best to find the therapy to reverse kidney function. Now if you want to know more information about FSGS or ask for treatment suggestions, you can contact our online doctors, leave us messages or send email to kidneyhospitalabroad@hotmail.com, we will reply you within 24 hours.
Study Backs Renal Transplantation in HIV-Infected Patients
Many transplanted kidneys come from donors who have died. Some come from a living family member. The kidney was the easiest organ to transplant: tissue typing was simple, the organ was relatively easy to remove and implant, live donors could be used without difficulty, and in the event of failure, kidney dialysis was available from the 1940s. Often, the new kidney will start making urine as soon as your blood starts flowing through it. But sometimes it takes a few weeks to start working.
Renal transplantation in HIV-infected patients is associated with graft and overall survival rates similar to those of HIV-negative patients, except in cases of co-infection with hepatitis C virus (HCV), according to a new study.
The study, led by Jayme E. Locke, MD, of the University of Alabama at Birmingham, is the first national study examining outcomes among the entire U.S. cohort of HIV-positive kidney transplant recipients and comparing their outcomes to appropriately matched HIV-negative controls.
The study included 510 HIV-infected renal transplant patients and 94,948 HIV-negative controls. The 5- and 10-year graft survival among the HIV-infected patients was 68.9% and 49.5%, respectively, but was highest among those who were infected only with HIV (mono-infected) but not HCV (75% and 55.9%, respectively), Dr. Locke and colleagues reported online ahead of print in the Journal of the American Society of Nephrology. Among patients co-infected with HIV and HCV, the 5- and 10-year graft survival rates were 49.9% and 25.9%, respectively.
The researchers compared the HIV group with a matched group of HIV-negative controls. Compared with the control group, the HIV-infected patients overall had significantly lower 5- and 10-year graft survival rates (69.2% vs. 75.3% and 49.8% vs. 54.4%, respectively). The 5- and 10-year graft survival rates did not differ significantly between mono-infected HIV patients and controls (75.0% vs. 75.8% and 55.9% vs. 56.0%, respectively). The 5- and 10-year survival rates were significantly worse for patients co-infected with HIV and HCV than for matched HIV-negative controls infected with HCV (52.0% vs.64.0% and 27.0% vs. 36.2%, respectively).
Patient survival rates among all HIV-infected recipients were 83.3% and 51.5% at 5 and 10 years, respectively. The rates were higher among the mono-infected HIV patients (88.7% and 63.5%, respectively) than the co-infected patients (66.3% and 29.3%).
Additionally, compared with appropriately matched HIV-negative controls, the HIV-infected patients had similar 5-year patient survival rates (83.5% and 86.2%), but significantly lower 10-year survival rates (51.6% vs. 72.1%). The 5- and 10-year patient survival rates did not differ significantly between the mono-infected HIV patients and HIV-negative/HCV-negative controls (88.7% and 89.1% and 63.5% and 77.6%). Co-infected patients, however, had significantly worse survival at 5 and 10 years compared with HIV-negative/HCV-positive controls (67.0% vs.78.6% and 29.3% vs. 56.2%, respectively).
Renal transplantation in HIV-infected patients is associated with graft and overall survival rates similar to those of HIV-negative patients, except in cases of co-infection with hepatitis C virus (HCV), according to a new study.
The study, led by Jayme E. Locke, MD, of the University of Alabama at Birmingham, is the first national study examining outcomes among the entire U.S. cohort of HIV-positive kidney transplant recipients and comparing their outcomes to appropriately matched HIV-negative controls.
The study included 510 HIV-infected renal transplant patients and 94,948 HIV-negative controls. The 5- and 10-year graft survival among the HIV-infected patients was 68.9% and 49.5%, respectively, but was highest among those who were infected only with HIV (mono-infected) but not HCV (75% and 55.9%, respectively), Dr. Locke and colleagues reported online ahead of print in the Journal of the American Society of Nephrology. Among patients co-infected with HIV and HCV, the 5- and 10-year graft survival rates were 49.9% and 25.9%, respectively.
The researchers compared the HIV group with a matched group of HIV-negative controls. Compared with the control group, the HIV-infected patients overall had significantly lower 5- and 10-year graft survival rates (69.2% vs. 75.3% and 49.8% vs. 54.4%, respectively). The 5- and 10-year graft survival rates did not differ significantly between mono-infected HIV patients and controls (75.0% vs. 75.8% and 55.9% vs. 56.0%, respectively). The 5- and 10-year survival rates were significantly worse for patients co-infected with HIV and HCV than for matched HIV-negative controls infected with HCV (52.0% vs.64.0% and 27.0% vs. 36.2%, respectively).
Patient survival rates among all HIV-infected recipients were 83.3% and 51.5% at 5 and 10 years, respectively. The rates were higher among the mono-infected HIV patients (88.7% and 63.5%, respectively) than the co-infected patients (66.3% and 29.3%).
Additionally, compared with appropriately matched HIV-negative controls, the HIV-infected patients had similar 5-year patient survival rates (83.5% and 86.2%), but significantly lower 10-year survival rates (51.6% vs. 72.1%). The 5- and 10-year patient survival rates did not differ significantly between the mono-infected HIV patients and HIV-negative/HCV-negative controls (88.7% and 89.1% and 63.5% and 77.6%). Co-infected patients, however, had significantly worse survival at 5 and 10 years compared with HIV-negative/HCV-positive controls (67.0% vs.78.6% and 29.3% vs. 56.2%, respectively).
Older Donor Kidneys Good for Seniors
We compared graft and patient outcomes of patients on maintenance dialysis after transplantation with OLD kidneys to those receiving younger live donor (YLD) kidneys and deceased donor (DD) kidneys. Competing risks models with matched controls were used to study the independent association between older donor age and allograft survival, accounting for the competing risk of recipient mortality as well as other transplant factors. 21.6 percent), patients who received older donated kidneys were no more likely to die within a decade of transplantation than those whose kidney donors were between 50 and 59.
(HealthDay News) -- Older patients who need a kidney transplant are better off receiving an available organ from an older deceased donor rather than waiting for one from a younger donor, according to a new study published online in the Journal of the American Society of Nephrology.
While kidneys from older donors can't provide younger patients with a lifetime of kidney function, they are suitable for older people because of their shorter life expectancy, the researchers explained. Even though more than 100,000 people in the United States are waiting for a kidney transplant, most kidneys from deceased donors 65 and older are discarded, the study authors said. Making greater use of those kidneys could shorten kidney transplant waiting lists.
The researchers analyzed data from Europe and the United States. They found that people aged 60 and older who need a kidney transplant are better off getting a kidney from a deceased older donor right away, rather than waiting for an organ from a younger donor.
"Older patients derive a survival benefit from rapid transplantation with an older donor kidney, while younger patients do not derive a benefit from transplantation from an older kidney," study co-leader John Gill, M.D., of the University of British Columbia in Vancouver, Canada, said in a journal news release. "Ensuring older patients can access older donor kidneys should be a priority in the United States. This may involve increased utilization of older donor kidneys or possibly excluding younger patients from receiving these kidneys," he added. Our email is kidneyhospitalabroad@hotmail.com.
(HealthDay News) -- Older patients who need a kidney transplant are better off receiving an available organ from an older deceased donor rather than waiting for one from a younger donor, according to a new study published online in the Journal of the American Society of Nephrology.
While kidneys from older donors can't provide younger patients with a lifetime of kidney function, they are suitable for older people because of their shorter life expectancy, the researchers explained. Even though more than 100,000 people in the United States are waiting for a kidney transplant, most kidneys from deceased donors 65 and older are discarded, the study authors said. Making greater use of those kidneys could shorten kidney transplant waiting lists.
The researchers analyzed data from Europe and the United States. They found that people aged 60 and older who need a kidney transplant are better off getting a kidney from a deceased older donor right away, rather than waiting for an organ from a younger donor.
"Older patients derive a survival benefit from rapid transplantation with an older donor kidney, while younger patients do not derive a benefit from transplantation from an older kidney," study co-leader John Gill, M.D., of the University of British Columbia in Vancouver, Canada, said in a journal news release. "Ensuring older patients can access older donor kidneys should be a priority in the United States. This may involve increased utilization of older donor kidneys or possibly excluding younger patients from receiving these kidneys," he added. Our email is kidneyhospitalabroad@hotmail.com.
Kidney Transplantation More Successful in HIV Than Hepatitis C
kidney transplantation may be the treatment option that allows you to live much like you lived before your kidneys failed. During a transplant, the surgeon places the new kidney in your lower abdomen and connects the artery and vein of the new kidney to your artery and vein. Exchanges and chains are a novel approach to expand the living donor pool. "The healthy kidney is transported in cool salt water (saline) that preserves the organ for up to 48 hours".
Deirdre Sawinski, M.D., of the University of Pennsylvania School of Medicine in Philadelphia, and colleagues examined data from 124,035 adults who received kidney transplants between 1996 and 2013. The researchers found a 3-year survival rate of 89% for those with HIV -- nearly the same as the 90% survival seen among uninfected patients. However, survival rates were lower -- 84% -- for those with hepatitis C, and 73% for those infected with both HIV and hepatitis C.
"Our hope is that these study findings result in greater access to transplantation for HIV patients," Sawinski said in a university news release. She also hopes the findings will spur "the kidney transplant community to focus on eradicating hepatitis C in transplant patients -- either pre-transplant or if that's not possible, immediately post-transplant -- to ensure better outcomes for these patients."
Currently, HIV patients must have an undetectable viral load to receive a kidney transplant, but the same requirement does not apply to hepatitis C patients, the researchers explained. The study authors said that less than 25% of transplant centers in the United States offer kidney transplants to HIV patients. Nationwide, fewer kidney transplants are done in people with HIV than those with hepatitis C.
Our email is kidneyhospitalabroad@hotmail.com.
Deirdre Sawinski, M.D., of the University of Pennsylvania School of Medicine in Philadelphia, and colleagues examined data from 124,035 adults who received kidney transplants between 1996 and 2013. The researchers found a 3-year survival rate of 89% for those with HIV -- nearly the same as the 90% survival seen among uninfected patients. However, survival rates were lower -- 84% -- for those with hepatitis C, and 73% for those infected with both HIV and hepatitis C.
"Our hope is that these study findings result in greater access to transplantation for HIV patients," Sawinski said in a university news release. She also hopes the findings will spur "the kidney transplant community to focus on eradicating hepatitis C in transplant patients -- either pre-transplant or if that's not possible, immediately post-transplant -- to ensure better outcomes for these patients."
Currently, HIV patients must have an undetectable viral load to receive a kidney transplant, but the same requirement does not apply to hepatitis C patients, the researchers explained. The study authors said that less than 25% of transplant centers in the United States offer kidney transplants to HIV patients. Nationwide, fewer kidney transplants are done in people with HIV than those with hepatitis C.
Our email is kidneyhospitalabroad@hotmail.com.
Subscribe to:
Posts (Atom)